Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

3371 - 3380 of 4611 results found

SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022

Date
Wednesday, May 31, 2023 - 4:00 AM
Description
CONCLUSIONS: Despite previously reported low numbers of COVID-19 cases and related deaths in Uganda, high SARS-CoV-2 seroprevalence and increasing antibody levels among blood donors indicated that the country experienced high levels of infection over

Subglottic Hemangioma: A Hidden Mass Presenting in an Unusual Age Group

Date
Wednesday, May 31, 2023 - 4:00 AM
Description
Subglottic hemangiomas are rare in adulthood. The presence of the lesion in the subglottic region makes it even more unusual. Moreover, these lesions do not have a typical course and involution changes as seen in the infantile forms. An elderly

Strategies to Support Faculty Caregivers at U.S. Medical Schools

Date
Wednesday, May 31, 2023 - 4:00 AM
Description
CONCLUSIONS: The COVID-19 pandemic presents a disruptive opportunity to translate lessons learned into positive change to better support faculty caregivers, particularly women and underrepresented in medicine faculty. This study's findings provide a

Structural under-reporting of informed consent, data handling and sharing, ethical approval, and application of Open Science principles as proxies for study quality conduct in COVID-19 research: a systematic scoping review

Date
Wednesday, May 31, 2023 - 4:00 AM
Description
BACKGROUND: The COVID-19 pandemic required science to provide answers rapidly to combat the outbreak. Hence, the reproducibility and quality of conducting research may have been threatened, particularly regarding privacy and data protection, in

SARS-CoV-2 spike S2-specific neutralizing antibodies

Date
Wednesday, May 31, 2023 - 4:00 AM
Description
Since the onset of the coronavirus disease 2019 (COVID-19), numerous neutralizing antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and authorized for emergency use to control the pandemic